Comparative effectiveness of angiotensin ii receptor blockers versus angiotensin-converting enzyme inhibitors in acute myocardial infarction

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

About the speaker

Doctor Pengfei Sun

Tianjin Medical University General Hospital, Tianjin (China)

8 More presentations in this session

Presentation thumbnail

Discussant - Pharmacotherapy

Presentation thumbnail

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Ph2 Trial of Pacibekitug SC Quarterly or Monthly in Patients with Elevated hs-CRP and Chronic Kidney Disease: TRANQUILITY 90-Day Results

Professor D. Bhatt (New York City, US)

Presentation thumbnail

SGLT2 inhibitors on the prevention of contrast-induced acute kidney injury in patients with type 2 diabetes after coronary revascularization: a systematic review and meta-analysis

Doctor K. Dimitriadis (Athens, GR)

Presentation thumbnail

GLP-1 RAs reduce mortality and cardiovascular events across the spectrum of treated patients: a systematic review and meta-analysis

Doctor M. Galli (Rome, IT)

Presentation thumbnail

Comparative effectiveness of GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT-2 inhibitors on cardiovascular outcomes: A comprehensive Bayesian network meta-analysis with intervention ranking

Doctor M. Rahman (Flushing, US)

Access the full session

Session thumbnail

New perspectives in cardiology (3) - Pharmacotherapy

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Session

Novel pharmacological approaches in acute coronary syndromes

Congress Session

Novel pharmacological approaches following an acute coronary syndrome

Congress Session

Key takeaways from ESC Congress 2025 together with World Congress of Cardiology (2)

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources